Return to: Medical School : Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Department of Urologic Surgery in the Medical School
Whats Inside
Contact Us

Academics
Faculty
Residency Program
Medical Students
Continuing Medical Education

Divisions
Center for Prostate Cancer
Center for Clinical Trials
Minimally Invasive Urology

Patient Care
Clinic Information
Specialties
Patient Resources

Urology Home

SOUP Administrative Center (login required)

Make a Gift to Urologic Surgery

University of Minnesota Physicians.  Clinic appointment and referral information.

Urology > Faculty > Jon L. Pryor, M.D. > Curriculum Vitae
Jon L. Pryor, M.D.


Printer-friendly version   Mail this page to a friend

Curriculum Vitae
Jon L. Pryor, M.D.


APPOINTMENTS

1991: Assistant Professor (primary appointment), Departments of Urologic Surgery, University of Minnesota

1991: Assistant Professor (joint appointment), Department of Cell Biology and Neuroanatomy, University of Minnesota

1992: Graduate Faculty, Department of Obstetrics and Gynecology, University of Minnesota Hospital and Clinics

1993 -1995: Clinic Director, Department of Urologic Surgery

1993: Assistant Professor (joint appointment), Department of Obstetrics and Gynecology; Co-Director of University Reproductive Health Laboratory

1996: Associate Professor with Tenure (primary appointment), Department of Urologic Surgery, University of Minnesota

1996: Associate Professor (joint appointments), Department of Cell Biology and Neuroanatomy and Department of Obstetrics and Gynecology, University of Minnesota

1997-1998: Director, Center for Men's Health and Infertility Reproductive Health Associates, St. Paul, Minnesota

1997: Co-Editor In-Chief, Journal of Andrology

2000: Interim Chair and Residency Program Director, Department of Urologic Surgery

Top of Page

EDUCATION

1975-1979: B.A., Carleton College
1979-1983: M.D., University of Minnesota Medical School
1989: M.S., University of Virginia Graduate School of Arts and Sciences

Top of Page

POSTGRADUATE TRAINING

1983-1984: Internship, Surgery, Hennepin County Medical Center, Minneapolis, Minnesota

1984-1985: Residency, Surgery, Hennepin County Medical Center, Minneapolis, Minnesota

1985-1989: Residency, Urology, University of Virginia, Charlottesville, Virginia

1989-1991: Research Fellow, American Foundation of Urologic Disease Scholar/Burroughs Wellcome Fellow, Departments of Cell Biology/Neuroanatomy and Urologic Surgery, University of Minnesota, Minneapolis, Minnesota

Top of Page

LICENSURE and BOARDS

Minnesota License, Diplomate of the American Board of Urology, 1994

Top of Page

ORGANIZATION

American Society of Andrology
American Society of Reproductive Medicine
American Urological Association North Central Section (AUA)
Reproductive Immunology Special Interest Group (ASRM)
Society For Basic Urologic Research
Society for the Study of Male Reproduction (AUA)
Society for Study of Impotence

Top of Page

HONORS

Phi Kappa Phi Honor Society
1989: Honorable Mention, AUA/Circon ACMI Prize Essay Contest
1989: Student Merit Award, American Society of Andrology
1994: Nominated for MMF Distinguished Teaching Award
2000: Finalist for Postbaccalaureate, Graduate, and Professional Education Award, University of Minnesota

Top of Page

TEACHING RESPONSIBILITIES

1990-1993: Course Director, Urology Basic Science Forum\

1991-present: Lecturer, Gross Anatomy and Histology, University of Minnesota Medical School

1995-present: Lecturer, Human Sexuality, University of Minnesota Medical School

1992-1995: Course Director, Urology 5200 (2-week required surgical sub-specialty course)

1999-present: Lecturer, Clinical Coorelations

2000-present: Residency Program Director

Top of Page

VISITING PROFESSORSHIPS

1994: University of Wisconsin Department of Surgery (Division of Urology)
1997: Brook Army Medical Center and San Antonio Medical Society
1997: Mexican Society of Urology and residency programs
1997: Tulane Medical Center Department of Urology
1998: University of Cincinnati Medical Center, Division of Urology
1999: University of Texas San Antonio
2000: William Beaumont Department of Urology
2001: Yale University Department of Urology

Top of Page

CORPORATE BOARDS

1995-1998: Mediject Medical Advisory Board
1996-present: Gain, Inc. Medical Advisory Board
1999: Schering-Plough Vasomax Primary Care Advisory Board
1998-1999: Schering-Plough Vasomax Advisory Board
1999-present: Shepard Labs Board of Directors

Top of Page

COMMITTEE SERVICE

1991-1992
American Society of Andrology, By-Laws Committee, Abstract Committee
University of Minnesota Clinical Associates (UMCA), Board of Directors

1992-1993
American Society of Andrology, Membership Committee
University of Minnesota Ambulatory Care Systems and Task Force
University of Minnesota Clinical Associates (UMCA), Board of Directors
RESOLVE, Board of Directors

1993-1994
American Society of Andrology, Publications Committee, Membership Committee
American Fertility Society, Patient Education Committee
University of Minnesota Chair, Search Committee for Director of Reproductive Endocrinology Ambulatory Care Management Committee

1994-1995
American Society of Andrology, Executive Council Publications Committee
American Fertility Society, Chair, Post-Graduate Course, Patient Education Committee
Ad Hoc Review Group, Research on HIV Infection in the Genitourinary Tract NIH-NIDDK Washington, D.C.

1995-1996
American Society of Andrology, Chair, Post-Graduate Course, Executive Council Program Committee, Local Arrangements Committee, Publications Committee, Long-Range Planning Committee, Educational Policy Committee
American Society for Reproductive Medicine, Patient Education Committee, Nominations Committee

1996-1997
American Society of Andrology, Executive Counci, l CME Liaison
University of Minnesota, Chair, Search Committee for Pediatric Urology Chair, Search Committee for Assistant to the Chair, Department of Urologic Surgery

1997-1998
Ad Hoc Review Group, Special Emphasis Panel, Declining Sperm Counts, NICHD

1998
Special Emphasis Panel, Specialized Cooperative Centers Program in Reproduction Research, NICHD

2000-present
American Foundation for Urologic Disease, Reproductive Health Council

Top of Page

EDITORIAL RESPONSIBILITIES

1997-present: Co-Editor In-Chief, Journal of Andrology
Associate Editor: Glenn's Urologic Surgery (5th Edition)
1993-1997: Editorial Boards, Investigative Urology
1994-1997: Editorial Boards, Journal of Andrology

Reviewer for:
Human Reproduction
International Journal of Andrology
Journal of Andrology
Journal of Urology
Urology Journal of Clinical Endocrinology and Metabolism Fertility and Sterility

Top of Page

FUNDING

1991-1992: University of Minnesota Graduate School Grant-In Aid of Research (J. Pryor, P.I.)

1992-1993: Minnesota Medical Foundation Equipment Grant (J. Pryor, P.I.)

1992-1997: National Institute of Child Health and Human Development, Clinical Investigator Award Grant (J. Pryor, P.I.)

1994-1995: Minnesota Medical Foundation Grant (J. Pryor, P.I.)

1995-1996: Promega Grant Genetics Study (J. Pryor, P.I.)

1996-1997: Summit Medical Systems, Inc., Development of an Infertility Database (J. Pryor, P.I.)

1998: Merck Effect of Finasteride 1 mg on Serum PSA in Men with Androgenetic Alopecia (J. Pryor, Co - P.I.)

1998: VIVUS, Inc., Evaluation of the Safety and Efficacy of Transurethral Alprostadil and Prozon HCl used in Combination for the Treatment of Erectile Dysfunction (J. Pryor, P.I.)

1998: VIVUS, Inc., Long-term Evaluation of the Safety and Efficacy of Transurethral Alprostadil and Prozon HCl used in Combinationforhe Treatment of Erectile Dysfunction (J. Pryor, P.I.)

1998: N.I.H., US Study of Semen Quality in Partners of Pregnant Women (J. Pryor, Co-P.I.; Dr. Redmon did most of the work, though Dr. Pryor participated, especially in the initial design and setting up the study.)

1999: Schering Plough, An Open-Label Trial of Vasomax (Oral Phentolamine) in Spinal Cord Injured Patients with Mild to Moderate Erectile Dysfunction (J. Pryor, P.I.)

1999: TAP Pharmaceuticals, A Phase III at Home Use Study Evaluating the Efficacy and Safety of Escalating Roses of Uprima 2, 3, and 4 mg in the Treatment of Patients with Erectile Dysfunction (J. Pryor, P.I.)

2000: SDF Consultants, Effect of a Dietary Food Supplement Containing Carnitine on Sperm Motility (J. Pryor, P.I.)

2000: TAP Pharmaceuticals, A Phase III Crossover Study Evaluating the Efficacy and Safety of Uprima (Apomorphine HC1 Tablets) Sublingual (2,3,4,mg) in Combination with Sildenafil Citrate (25 or 50mg) in the Treatment of Male Erectile Dysfunction (J. Pryor, P.I.)

2000: PARKE-DAVIS, A double-blind, placebo-controlled, parallel group study to assess the effect of Pregabalin on reproductive function in healthy male subjects (J. Pryor, P.I.)

2000: MACROCHEM Corporation, A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of Topiglan (Topical Gel Formation of Alprostadil and Sepa) For the Treatment of Male Erectile Dysfunction in an At-Home Setting (J. Pryor, P.I.)

Top of Page

PUBLICATIONS

Books
1. Robaire B, Pryor JL, Trasler JM. Handbook of andrology. Lawrence: Allen Press; 1995.

2. Pryor JL, Glass SL. It's in the male: everyone's guide to men's health. Minneapolis: Appleday Press; 2000.

3. Associate Editor for the Fifth Edition of Glenn's Urologic Surgery, 1998.

Chapters
1. Pryor JL, Howards SS. Varicocele. In: Tanagho, Lue, McClure, editors. Contemporary management of impotence and infertility. Baltimore: Williams and Wilkins Company; 1988.

2. Pryor JL, Becher EF, Sidi AA. Overview of balloon catheters for transurethral dilatation of the prostate. In: Seminars in interventional radiology. Thieme Medical Publishers, Inc.; 1991.

3. Pryor JL. Androgen supplementation causes BPH: Proceedings of the 2nd international androgen workshop. New York: John Wiley & Sons; 1996.

4. Roberts KB, Pryor JL. Anatomy and physiology of the male reproductive tract. In: Hellstrom WJG, editor. Male infertility and sexual dysfunction. New York: Springer; 1997.

5. Schow DA, Pryor JL. Vasectomy. In: Graham SD, Glenn JF. Glenn's urologic surgery. Philadelphia: Lippincott-Raven Publishers; 1998.

6. Pryor JL, Roberts KP. Genetics of male infertility: essentials for the clinician. In: Vaughan ED Jr, Perlmutter AP, editors. Atlas of clinical urology: Impotence and infertility, Vol I. Philadelphia: Current Medicine; 1999.

7. Ober C, Verp MS, Roberts KP, Pryor JL. Genetics of infertility and pregnancy loss. In: King RA, Rotter JI, Motulsky AG, editors. The genetic basis of common diseases. New York: Oxford University Press; 2000.

8. Redmon JB, Pryor JL. Male menopause. In: Teichman J, editor. 20 common genitourinary problems in primary care. McGray-Hill. In press.

Articles
1. Pryor JL, Howards SS. Varicocele. Urol Clin North Am 1987;14:499-513.

2. Pryor JL, Carey PO, Lippert M. Migration of silicone ureteral catheters. J Endourol 1988;2:283-285.

3. Pryor JL, Hurt S, Caloras D, Turner TT, Flickinger C, Howards SS. Histologic analysis of orchidopexy in a cryptorchid rabbit model. J Urol 1989;142:412-417.

4. Pryor JL, Krieg RJ, Evans WS, Batson J, Turner TT. Luteinizing hormones secretion by male rate pituitary cells perifused in vitro: effect of experimental left varicocele and orchiectomy. J Androl 1989;10:372-377.

5. Pryor JL, Gillenwater JY. A double channel cystoscope for stone manipulation prior to ESWL. J Urol 1989;142:778-779.

6. Selby JB Jr, Pryor JL, Tegtmeyer CJ, Gillenwater JY. Inferior vena cava invasion by renal cell carcinoma: false positive diagnosis by venacavography. J Urol 1990;143:464-467.

7. Pryor JL, Jenkins AD. Use of double-pigtail stents in extracorporeal shock wave lithotripsy (ESWL). J Urol 1990;143:475-478.

8. Pryor JL, Langley MJ, Jenkins AD. A randomized comparison of symptom characteristics of indwelling ureteral catheters. J Urol 1991;145:719-722.

9. Pryor JL, Mills S, Howards SS. Injury to the pre-pubertal vas deferens: I. histologic analysis of the pre-pubertal human vas. J Urol 1991;146:433-476.

10. Pryor JL, Fusia T, Mercer M, Mills S, Howards SS. Injury to the pre-pubertal vas deferens: II. experimental repair. J Urol 1991;146:477-480.

11. Ferral H, Wegryn SA, Crain MR, Miltz-Miller SE, Bjarnason H, Dietz CA Jr, Pryor JL, Hunter DW, Castaneda-Zuniga WR. Vascular evaluation of impotence. Lippincott's Reviews: Radiology 1992;1:604-609. 

12. Pryor JL, Xu W, Hamilton DW. Immunodetection after complete destaining of coomassie blue stained proteins on Immobilon-PVDF. Analytical Biochemistry 1992;202:100-104.

13. Reinberg Y, Matas A, Manivel JC, Gonzalez R, Gillingham KJ, Pryor JL. Outcome of renal transplantation or dialysis in patients with a history of renal cancer. Cancer 1992;70:1564-1567.

14. Sneiders A, Pryor JL. Percutaneous nephrostomy drainage in the treatment of severe hemorrhagic cystitic. J Urol 1993;150:966-967.

15. Sylora JA, Pryor JL. Varicocele: current treatment and management. Current Therapy in Endocrinology and Metabolism 1994;5:309-314.

16. LeRoy SC, Pryor JL. Severe penile erosion after use of a vacuum suction device for management of erectile dysfunction in a spinal cord injured patient. Paraplegia 1994;32:120-123.

17. Pryor JL, Watson LR, Abbitt P, Howards SS, Day D, Gonzalez R, Reinberg Y. Scrotal ultrasound for evaluation of testicular torsion: sonographic findings and adverse clinical implications. J Urol 1994;151:693.

18. Pryor JL, Xu W, Moore A, Ensrud KM, Hamilton DW. A putative rat sperm phospholipid binding protein: purification and partial characterization. Mol Reprod Dev 1994;39:289-296.

19. Pryor JL, Leroy SC, Nagel TC, Hensleigh HC. Vibratory stimulation for treatment of anejaculation in quadriplegic males. Arch Phys Med Rehabil 1995;76:59-64.

20. Samper JC, Hamilton DW, Pryor JL, Loseth KJ, Troedsson MTH, Crabo BG. Mechanism of sephadex trapping of capacitated stallion spermatozoa. Biol Reprod 1995;Mono 1:729-737.

21. Swanlund DJ, Diaye MR, Loseth KJ, Pryor JL, Crabo BG. Diverse testicular responses to exogenous growth hormone and follicle-stimulating hormone in prepubertal boars. Biol Reprod 1995:53:749-757.

22. Pryor JL. What are the unique chromosomal events leading to the formation of a haploid male germ cell? J Androl 1995;Suppl S.

23. Kukadia AN, Ercole CJ, Gleich P, Hensleigh H, Pryor JL. Testicular trauma: potential impact on reproductive function. J Urol 1996;156:1643-1646.

24. Hensleigh HC, Javkin PD, Tagatz GE, Pryor JL. Evaluation for antisperm antibodies after storage of sperm in test-yolk buffer. Fertil Steril 1996;66:454-458.

25. Pryor J, Roberts K, Muallem A, Nolten W, Meisner L, Kent-First MG. Analysis of Y chromosomal microdeletions in 200 consecutive infertility patients. N Engl J Med 1997;336:534-539.

26. Long RJ, Roberts KP, Wilson MJ, Ercole CJ, Pryor JL. Prostate cancer 1996: a clinical and basic science review. J Androl 1997;18:15-20.

27. Schow DA, Redmon B, Pryor JL. Male Menopause. Post Grad Med 1997;101:62-79.

28. Sundaram CP, Thomas W, Pryor LE, Billups K, Pryor JL. Long-term follow-up of patients on injection therapy for erectile dysfunction. Urology 1997;49:932-935.

29. Metz ME, Pryor JL, Nesvacil L, Abuzzahab F, Koznar J. Premature ejaculation: a psychophysiologic review. J Sex and Marital Therapy 1997;23:3-23.

30. Skoog S, Roberts KP, Pryor JL. The adolescent varicocele: What's new with an old problem in young patients? Pediatrics 1997;100:112-122.

31. Pinke LA, Swanlund DJ, Roberts KP, Hensleigh HC, McCarthy JB, Pryor JL. The presence of fibronectin on mammalian sperm is correlated with morphological and functional abnormalities. J Urol 1997;158:936-941.

32. Johnson J, Dykstra D, Brown J, Kringstad B, Pryor J. A surface swab method for culturing foley catheters assays the pericatheter (urethral) but not the urine (luminal) microbial population. J Lab Clin Med 1997;130:102-109.

33. Roberts K, Kent-First M, Pryor J. PCR detection of Y chromosome microdeletions in infertile men. Biotech Lab Intl 1997;2:14-17.

34. Mahoney MC, Swanlund DJ, Billeter M, Roberts K, Pryor JL. Regional distribution of 5a-reductase type 1 and type 2 mRNA along the human epididymis. Fertil Steril 1998;69:1116-1121.

35. Pryor JL, Roberts KP. Principles of sequence-tagged site selection in screening for Y deletions. Human Repro 1998;13:1768.

36. Wilson M, Davis A, Ercole C, Pryor J, Hensleigh H, Kaye K, Dawkins H, Wasserman N, Reddy P, Ahmed K. Protein kinase CK2 activities in human prostatic and seminal-vesicle secretions and seminal plasma. J Androl 1998;19:754-760.

37. Pryor JL. The costabile/spevak article reviewed: cancer and male factor infertility: it may only take one sperm, but make sure it's there. Oncology 1998;12:566-570. 

38. Wilson MJ, Ruhland AR, Pryor JL, Ercole C, Sinha AA, Hensleigh H, Kaye KW, Dawkins HJS, Wasserman NF, Reddy P, Ahmed K. Prostate specific origin of dipeptidylpeptidase IV (CD-26) in human seminal plasma. J Urol 1998;160:1905-1909.

39. Pryor JL. Editorial Comment to: Meyer JM, Thibe P. The Correlation among cavernous pressure, penile rigidity and resistence index. J Urol 1998;160:63-66.

40. Lipshultz LI, Nagler H, Oates R, Pryor JL, Turek P. How effective is genetic testing for male infertility? Contemporary Urology 1998 May:42-60.

41. Schow DA, Pryor JL. Vasectomy. Urol Clin 1999.

42. Kent-First M, Muallem A, Shultz J, Pryor J, Roberts K, Nolten W, Meisner L, Chandley A, Gouchy G, Jorgensen L, Havighurst T, Grosch J. Defining regions of the Y-chromosome responsible for male infertility and identification of a fourth AZF region (AZFd) by Y-chromosome microdeletion detection. Mol Repro & Devel 1999;53:27-41.

43. Zapzalka D, Redmon B, Pryor J. A survey of oncologists on sperm cryopreservation and assisted reproductive techniques for male cancer patients. Cancer 1999;86:1812-1817.

44. Schacker T, Little S, Connick E, Gebhard-Mitchell K, Zhang Z, Krieger J, Pryor JL, Havlir D, Wong JK, Richman D, Corey L, Haase AT. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications of timing of antiretroviral therapy. J Infectious Diseases 2000;181: 354-7.

45. Metz ME, Pryor JL. Premature ejaculation: a psychophysiological approach for assessment and management. Journal of Marital and Sexual Therapy 2000;26:4, 293-320.

46. Devireddy RV, Swanlund DJ, Roberts KP, Pryor JL, Bischof JC. The effect of extracellular ice and cryoprotective agents on the water permeability parameters of human sperm plasma membrane during freezing. Human Reproduction 2000;15:5, 1125-1135.

47. Lemasters GK, Perreault SD, Hales BF, Hatch M, Hirshfield AN, Hughes CL, Kimmel GL, Lamb JC, Pryor JL, Rubin C, Seed JG. Workshop to identify critical windows of exposure for children's health: reproductive health in children and adolescents work group summary. Environmental Health Perspectives 2000;108:3, 505-509.

48. Pryor JL, Hughes C, Foster W, Hales BF, Robaire B. Critical windows of exposure for children's health: the reproductive system in animals and humans. Environmental Health Perspectives 2000;108:3, 491-503.

49. Carey P, Redmon JB, Pryor JL. Varicocele: the most common cause of male factor infertility? (submitted to Human Reproduction).

50. Pryor JL, Redmon JB. New therapies and delivery mechanisms for treatment of erectile dysfunction. Int'l Journal of Impotence Research 2000;12(4):S158-S162.

51. Eid JF, Nehra A, Andersson KE, Heaton J, Lewis RW, Morales A, Moreland RB, Mulcahy JJ, Porst H, Pryor JL, Sharlip ID, Wagner G, Wyllie M. First international conference on the management of erectile dysfunction: overview consensus statement. Int'l Journal of Impotence Research 2000;12(4):S2-S5

52. Schacker T, Little S, Connick E, Gebhard-Mitchell K, Zhang Z, Krieger J, Pryor JL, Havlir D, Wong J, Schooley J, Richman D, Corey L, Haase A. Productive infection of T Cells in lymphoid tissues during primary and early HIV. Journal of Infectious Diseases 2001;183:555-562.

53. Redmon JB, Pryor JL. Reproductive options for men with cancer. Coping. In press 2001.

Top of Page

ABSTRACTS/PRESENTATIONS

1. Pryor JL, Turner TT. Capillary permeability in the rat varicocele model. Presented at Annual Meeting of American Urological Association, Anaheim, CA, May 1987.

2. Pryor JL, Jenkins, A. Use of double-pigtail stents in extracorporeal shock wave lithotripsy (ESWL). Presented at Annual Meeting of American Urological Association, Boston, MA, June 1988.

3. Pryor JL, Krieg RJ, Evans WS, Turner TT. Luteinizing hormone secretion by male rat pituitary cells perifused in vitro: effect of experimental left varicocele and orchiopexy. Presented at American Society of Andrology, New Orleans, LA, 1989.

4. Pryor JL, Hurt GS, Caloras D, Turner TT, Flickinger C, Howards SS. Histologic analysis of orchiopexy in a cryptorchid rabbit model. Presented at Annual Meeting of American Urological Association, Dallas, TX, 1989.

5. Pryor JL, Langley MJ, Jenkins AD. A randomized comparison of indwelling ureteral catheters. Presented at Annual Meeting of American Urological Association, Dallas, TX, 1989.

6. Pryor JL, Mills S, Howards SS. Injury to the pre-pubertal vas deferens: histological analysis of the pre-pubertal human vas. Presented at Annual Meeting of American Society of Andrology, Columbia, SC, 1990.

7. Pryor JL, Fusia T, Mercer M, Mills S, Howards SS. Injury to the pre-pubertal human vas and experimental repair. Presented at Annual Meeting of American Urological Association, New Orleans, LA, 1990.

8. Pryor JL, Jaszca W, Manivel JC, Goswitz JJ, Chartrand SL, Reinberg Y. Morphologic and flow cystometric analysis of abnormal spermatogenesis and intratubular germ cell neoplasia (ITGCN). Presented at Annual Academy of Pathology Meeting, Chicago, IL, 1991.

9. Pryor JL, Reinberg Y, Matas A, Manivel JC, Gonzalez R, Gillingham KJ. Outcome of renal transplantation or dialysis in patients with a history of renal cancer. Presented at Annual Meeting of American Urological Association, Toronto, Canada, 1991.

10. Pryor JL, Ensrud KM, Hamilton DW. Tolerization and immunosuppression for selective production of monoclinal antibodies to human epididymal proteins. Presented at the American Society of Cell Biology, Boston, MA, 1991.

11. Pryor JL, Xu W, Hamilton DW. Immunodetection of coomassie blue strained proteins on Immobilon-PVDF: a new technique for destaining. Presented at the American society of Cell Biology, Boston, MA, 1991.

12. Pryor JL, Fursa T, Ensrud K, Hamilton DW. Selective production of monoclinal antibodies to human epididymal antigens and initial characterization studies. Presented at Annual Meeting of the American Urological Association, Washington, D.C., 1992.

13. Pryor JL. Lifestyles of the infertile. Keynote address for Resolve of the Twin Cities, University of Minnesota, Minneapolis, MN, 1993.

14. Pryor JL Wandlund DJ. Immunodetection/localization of a putative acrosomal antigen in the human male. Presented at the North American Testis Workshop, Tampa, FL, 1993.

15. Pryor JL. Diagnosis and treatment of prostatic disease: are we jumping the gun and/or missing the boat? Clinical debate: presented at the American Society of Andrology, Springfield, IL, 1994.

16. Pryor JL. The epididymis: function or fiction. Presented at the American Society of Andrology, Springfield, IL, 1994.

17. Pryor JL. What's up with impotence. Presented at the 39th Annual Meeting of the North Dakota Academy of Family Physicians, Fargo, ND, August 5, 1994.

18. Pryor JL. High impact infertility: the total work-up. Presented at the University of Wisconsin, Madison, WI, December 10, 1994.

19. Pryor JL, Coffey D. Will testosterone treatment lead to BPH (Debate). The Second International Androgen Workshop. Long Beach, CA, February 17-20, 1995.

20. Swanlund DJ, Roberts KP, Pryor JL. Identification and characterization of a human testis cDNA putatively encoding acrosomal protein 4A5. Presented at the XIII Testis Workshop: Cellular and Molecular Regulation of Testicular Cells, Raleigh, NC, March 30-April 1, 1995.

21. Pinke LA, Swanlund DJ, Roberts KP, Hensleigh HC, Hamilton DW, Pryor JL. Fibronectin localization on mammalian sperm. Presented at the 20th Annual Meeting of the American Society of Andrology, Raleigh, NC, March 31-April 4, 1995.

22. Sundaram CP, Sidi A, Pryor JL. Vasoactive intracavernosal pharmacotherapy: long-term follow-up. Presented at the 19th Annual Meeting of the American Urological Association, Inc., Las Vegas, NV, April 23-28, 1995.

23. Pryor JL. Testicular pain (or great balls of fire). Presented at Topics and Advances in Pediatrics. University of Minnesota, Minneapolis, MN, June 1995.

24. Pryor JL. What's up with impotence? Presented to the Minnesota Academy of Family Physicians, Minneapolis, MN, June 1995.

25. Pryor JL. Vasectomy and vasovasostomy. Presented at the Upper Midwest Chapter of the American Urological Association Allied Seminar, Bloomington, MN, October 14, 1995.

26. Pryor JL. Medical therapy of erectile dysfunction and update on evaluation of male infertility. William Beaumont Hospital-Royal Oak. 2nd U.S.-Japanese Seminar, Big Island, Hawaii, November 5-8, 1995.

27. Pryor JL. Male menopause. Presented at Minnesota Academy of Family Physicians 1996 Spring Refresher. Hyatt Regency Hotel, Minneapolis, MN, April 25-26, 1996.

28. Pryor JL. Bilateral effects of unilateral testicular disease. Presented at the American Society for Reproductive Medicine Annual Meeting. Boston, MA, November 2-6, 1996.

29. Pryor JL. Timing of insemination and pregnancy rates in female partners of the spinal cord injured male. Presented at the American Society for Reproductive Medicine Annual Meeting. Boston, MA, November 2-6, 1996.

30. Pryor JL. Isolation and characterization of the primary structure of testis-specific L-type calcium (Ca) channel: implications for contraception. Presented at the American Society for Reproductive Medicine Annual Meeting. Boston, MA, November 2-6, 1996.

31. Pryor JL. Male menopause. Presented at the New Horizons in Minnesota Medicine Spring Alumni Reunion Weekend. Minneapolis, MN, June 6, 1998.

32. Pryor JL. Infertility: my world and welcome to it. Presented at Frontiers in Reproduction Research: Implications Mini-Symposium. Woodshole, MA, June 10, 1998.

33. Pryor JL. Andrological highlights of the 1999 AUA annual meeting. American Urological Association Meeting. Dallas, TX, May 3, 1999.

34. Pryor JL. ICSI: results with MESA, TESA, PESA, and EEJ. Presented at the Annual Postgraduate Program: American Society of Reproductive Medicine. San Diego, CA, October 22, 2000.

35. Pryor JL. Current concepts in infertility. Presented at the North Central section Meeting of the AUA. Scottsdale, AZ, October 30, 2000.

36. Pryor JL. A new therapeutic option for male infertility: the clinical experience with carnitines. Presented at the Phillipines Medical Association and the U.S./Japan Urology Seminar, Manila, Phillipines, 1999.

37. Pryor JL. Invited speaker for the U.S./Japan Urology Seminar, Sappora, Japan, 2001.

Top of Page


Feedback | Notice of Privacy Practices


 
The University of Minnesota is an equal opportunity educator and employer.